ECM
CLDX icon

ExodusPoint Capital Management’s Celldex Therapeutics CLDX Stock Holding History

ExodusPoint Capital Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,244
Closed -$436K – 1522
2024
Q4 		$436K Buy
+17,244
New +$469K ﹤0.01% 1184
2024
Q3 		– Sell
-38,150
Closed -$1.41M – 1674
2024
Q2 		$1.41M Buy
+38,150
New +$1.44M 0.01% 909
2023
Q4 		– Sell
-26,434
Closed -$727K – 1538
2023
Q3 		$727K Buy
+26,434
New +$829K 0.01% 1092
2021
Q2 		– Sell
-135,552
Closed -$2.79M – 2400
2021
Q1 		$2.79M Sell
135,552
-35,039
-21% -$805K 0.04% 445
2020
Q4 		$2.99M Buy
+170,591
New +$3.07M 0.03% 398
2020
Q3 		– Sell
-58,415
Closed -$759K – 1800
2020
Q2 		$759K Buy
+58,415
New +$259K 0.02% 880

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return